GUMDROP : JHMI J0841 Phase I and II Study of High Dose IL2 -Aldesleukin- in Combination with the Histone Deacetylase Inhibitor Entinostat in Patients with Metastatic RCC

Created by Channing Paller, last modified by Nancy Dawson on Apr 28, 2013

Description:

Hist-confirmed mRCC, clear cell or predominantly clear cell; no prior chemo; optional biopsy and FDG-PET/CT

Link:

http://clinicaltrials.gov/ct2/show/NCT01038778

Site:

Johns Hopkins Hospital

Principal Investigator:

Michael Carducci, M.D.